A Real-World Analysis of the Clinical Journey, Diagnosis, and Monitoring Patterns of Patients With Alzheimer Disease by Stage in the United States
Open Access
- 1 August 2025
- journal article
- Published by SAGE Publications in American Journal of Alzheimer's Disease and Other Dementias®
- Vol. 40
Abstract
This study aimed to describe the clinical journey of patients with different stages of Alzheimer disease (AD). This was a cross-sectional survey of US primary care physicians (PCPs)/specialists and patients using the Adelphi Real World AD Disease Specific Programme™ (December 2022 – September 2023). Patients were stratified by disease severity and data are presented as the mean (SD) or frequencies/percentages. In the overall sample ( N = 990), mean time from symptom onset to first evaluation was 31.4 (40.6) weeks and mean time from evaluation to diagnosis was 14.2 (29.0) weeks (mild cognitive impairment due to AD, 12.0 [22.7] weeks; mild AD dementia, 15.7 [31.6] weeks; moderate AD dementia, 14.0 [29.9] weeks; severe AD dementia, 5.1 [9.6] weeks). 74.5% of the overall sample was initially evaluated by their PCP and 13.8% by a neurologist. Patients with AD experience many barriers during the diagnostic journey; however, PCPs and neurologists play key roles in early diagnosis.Keywords
Funding Information
- Novo Nordisk Inc.
This publication has 29 references indexed in Scilit:
- Individualized clinical management of patients at risk for Alzheimer's dementiaAlzheimer's & Dementia, 2019
- Longitudinal analysis of dementia diagnosis and specialty care among racially diverse Medicare beneficiariesAlzheimer's & Dementia, 2019
- Prevalence and determinants of undetected dementia in the community: a systematic literature review and a meta-analysisBMJ Open, 2017
- Trends in medication use in patients with type 2 diabetes mellitus: a long-term view of real-world treatment between 2000 and 2015Diabetes, Metabolic Syndrome and Obesity, 2016
- Evidence for validity of a national physician and patient-reported, cross-sectional survey in China and UK: the Disease Specific ProgrammeBMJ Open, 2016
- Potentially Unsafe Activities and Living Conditions of Older Adults with DementiaJournal of the American Geriatrics Society, 2016
- The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for reporting observational studiesInternational Journal of Surgery, 2014
- Impact of early intervention and disease modification in patients with predementia Alzheimer’s disease: a Markov model simulationClinicoEconomics and Outcomes Research, 2011
- Real-world physician and patient behaviour across countries: Disease-Specific Programmes – a means to understandCurrent Medical Research and Opinion, 2008
- Mapping Scores Onto Stages: Mini-Mental State Examination and Clinical Dementia RatingThe American Journal of Geriatric Psychiatry, 2006